A straightforward argument is presented to calculate the number of different major histocompatibility complex (MHIC) molecules in an individual that maximizs the probability of mounting immune responses against a large number of foreign peptides. It is assumed that increasing the number of MHC molecules per individual, n, has three differ- 
reduces the number of TCRs by negative selection. The mathematical analysis shows that n = 1/fmaximize the number of different TCRs that pass through positive and negative selection and that n = 2/f maximizes the probability to mount immune responses against a large fraction of foreign peptides. Here f is the fraction of TCRs deleted by one MHC molecule. Both results depend on approximations that are discussed in the paper. The model presented has implications for our understanding of the evolutionary forces acting on the MHC.
A major histocompatibiity complex (MHC) has been identified in all vertebrate species so far examined. Encoded within this gene complex are molecules that compose or contribute toward MHC heterodimers that can be expressed on cell membranes (1) . These molecules bind peptides de- with /32-microglobulin, encoded elsewhere in the genome, whereas both the a and f3 chains of class II molecules are encoded within the MHC. For most MHC loci, multiple alleles exist within the species (2) . As a consequence of this polymorphism and of alloreactivity, the capacity of a large proportion of the T-cell repertoire of any individual to respond to foreign MHC molecules and/or bound peptides from MHC-disparate individuals of the species (3), MHC disparities give rise to transplantation reactions in vivo (allograft rejection and graft-versus-host disease) and the allogeneic mixed leukocyte reaction in vitro.
Regarding class I molecules, it is notable that in all vertebrates examined, only two or three appear to function as strong transplantation antigens, even though the MHC may contain as many as 60 class I loci per haploid genome (rats) or perhaps as few as 7 (miniature swine), despite the potential for evolutionary duplication and diversification of individual loci. To date, the best-characterized MHC complexes are in mouse and human, H-2 and HLA, respectively (Fig. 1) . Of the 30 to 40 class I MHC loci identified within the H-2 complex of different mouse strains, only those within the K and D regions encode the "classical" class I molecules that are highly polymorphic, are expressed or can be induced on essentially all cell types, are implicated in physiological antigen presentation, and function as strong transplantation antigens; the comparable regions of the HLA complex are designated A, B, and C. In the mouse, only a single locus is present in the D region of some haplotypes, such as H-2b. In other haplotypes, such as H-2d, there is instead a cluster of five genes, but only two loci, D and L, are expressed; the remaining three loci do not encode antigen-presenting molecules and have no known function. In some haplotypes an additional K locus, K2, has been defined, but this locus represents a pseudogene in H-2k mice, for example, and its status is uncertain in other strains. Therefore, completely heterozygotic F1 mice express four to six different classical class I molecules-i.e., maternal and paternal alleles of K, D, and L, where present. The same is true for humans, where, in fact, there are few examples of T cells reactive to C-locus products.
Most mouse class I loci encode the relatively nonpolymorphic "nonclassical" Qa and Tla products (4), only some of which are detectable serologically, that are expressed in an apparently cell-restricted or tissue-specific manner, sometimes as phosphatidylinositol-linked membrane molecules or as secreted products. Homozygous mice of different strains express from =20 to 30 Qa and Tla class I loci, but because these loci are considerably less polymorphic than the classical genes, heterozygous mice express fewer than the theoretical maximum of 40-60 molecules.
Homologues of Qa and Tla products have yet to be identified in the human, although three nonclassical class I molecules, HLA-E, -F, and -G, have been identified in one haplotype (8) Proc. Natl. Acad. Sci. USA 89 (1992) 10897 and human DPA2, DPB2, DQB3, and DRB2; as yet no translation products have been identified from DNA and DNB transcripts, and the DQA2 and DQB2 genes are not known to be expressed. DMA and DMB correspond to the RING6 and RING7 loci (5). The following is not shown: the mouse class I-related loci of the Hmt and Mbl subfamilies and the CD1 family (4); two human class I-like loci, 1.7p mapping to the left of HLA-B, and HLA-X to the left of HLA-E (7); the human class II loci DRB4 and DRB5, either of which can be expressed instead of DRB3 in some haplotypes, although in others all three are absent; and a pseudogene mapping between the DRB loci and DRA. The maximum number of known classical class I and class II MHC molecules that could be expressed in homozygotic and heterozygotic (IE+) mice is a total of 7 and 18, respectively; the corresponding numbers for humans are 15 and 43. It is important to note that these values do not take into account the recently defined class II-related genes (see text). These numbers should be compared with the computed values in Table 1. II region of the human MHC, HLA-D, are DPAI and DPB1 (encoding the DP molecule); DQAJ and DQBI (for DQ); and DRA, DRBI, and DRB3 or -4 or -5 if present (for one or two DR molecules) (10) . The expression of class II molecules is more complicated than that of class I because ofthe potential for heterodimer formation between a and chains of different haplotypes and/or isotypes and because the human DRA and mouse Ea loci are essentially invariant. The predominantly expressed class II molecules are probably isotypematched as well as allele-matched. Allele-mismatched combinations have been detected functionally, using T-cell clones that recognize unique F1 determinants, as well as biochemically on the surface of transfected cells, but these are rare and their formation depends on the haplotypes involved. Mixed isotypes have also been detected in gene-transfected and tumor cell lines, but the general consensus is that these molecules are, at best, of only minor physiological significance for antigen presentation by normal cells. products. Thus, heterozygotic humans could potentially express a maximum of 40 of these MHC class II molecules (12 in homozygotes).
From the above, between 4 and 12 class II molecules could potentially be expressed in completely heterozygotic IE+ mice (only 2-4 in IE-strains) and 8-40 in humans, but the physiologically relevant number is thought to be much closer to the lower estimate. An additional set of MHC class II-related genes has also been defined (5, 6), the mouse Ma, MbN, and Mb2, and the human RING6 and RING7 (HLA-DMA and -DMB) loci (Fig. 1) . These loci could encode additional cell-surface heterodimers, but their function awaits definition. Furthermore, an unusual H-2 class II product, H-20, containing the 0(3 (formerly AP2) chain paired to a specific Oa chain, is expressed in thymic medulla and peripheral B cells (11) , which also express the EP33 chain-encoding gene, but the function of these molecules is likewise unclear at present. In addition, the class II regions of both mouse and human contain a number of other loci and homologous gene segments that cannot be, or are not known to be, expressed (Fig. 1 legend) Therefore,.were the number of MHC molecules expressed by any individual to increase, more self-peptides would be presented, and this presentation would result in deletion or inactivation of more of the total T-cell repertoire. This situation, in turn, would reduce the potential for inducing an immune response to any given organism.
The following mathematical analysis allows an estimation ofthe optimal number ofdifferent MHC molecules expressed per individual in order to achieve the maximum capacity to present and recognize foreign peptides with the minimum loss of functional T cells through negative selection.
Let To denote the total potential number of different TCRs that can be generated in the thymus before positive or negative selection. Let h be the fraction of (T cells bearing) TCRs that is positively selected by one MHC molecule. The number of different TCRs that are positively selected by n different MHC molecules is then given by To [1 - (1 -h)"]. Let f denote the fraction of (positively selected T cells bearing) TCRs that is deleted, anergized, or otherwise rendered tolerant by one MHC molecule. The fraction of TCRs remaining after negative selection by n MHC molecules is (1 -f)n. The total number of TCRs that pass through positive and negative selection exerted by n different MHC molecules is then given by T = T -(1 -h)n](1-f)". [1] Tn has a maximum for
This maximum represents the largest possible TCR repertoire in the periphery (after positive and negative selection). Assuming log(l -h) -h and log(1 -f) -f, we obtain 1 l ha n = -log +fJ [3] For h >> f this is approximately n = (log h -log f)/h; for h = fwe have n = log 2/f; and for h << fwe have n = I/f. It is tempting to assume that h is smaller thanfbecause only a small fraction of the randomly generated TCRs may be positively selected by a given MHC molecule, but a larger 10-10 9 19 39 99 The optimal number maximizes the size ofthe repertoire offoreign peptides that can be both presented by MHC molecules and recognized by TCRs. This maximum arises from the consideration that more MHC molecules can expand the T-cell repertoire (positive selection) and present a larger variety offoreign peptides but will, on the other hand, delete too many TCRs (negative selection).
Parameters q and f denote, respectively, the probability that (a T cell bearing) a given TCR binds to an arbitrary peptide-MHC complex, and the fraction of TCRs deleted (or rendered tolerant) by one MHC molecule. For this numerical example, other parameter values were chosen as To = 1010, h = 0.0001, and p = 0.001. fraction of those TCRs that are positively selected may be deleted afterward because of autoreactivity against MHC plus self-peptide. If this assumption is correct, then n = 1/f maximizes the variety ofTCRs that pass through positive and negative selection to compose the functional TCR pool in the periphery. This is an interesting result.
In the following we do not use any of the above approximations but proceed directly with Eq. 1. Let p denote the fraction of all foreign peptides that can bind to a single MHC molecule. If there are n different MHC molecules, then a given peptide will bind to exactly i of them with the probability (Q)pi(l -p)r-i. The probability that at least one ofthese complexes will be recognized by at least one out of the Tn different TCRs in the periphery is given by 1 -(1 -q)iTn. Here q is the probability that a given TCR binds to a given peptide-MHC complex. We can now express the probability that a given foreign peptide will be presented by an MHC molecule and that the resulting complex will be recognized by a TCR, as [4] 
To derive Eqs. 1 (14) . In this context the parameters h, f, and p represent average quantities.
The sum in Eq. 4 can be calculated exactly. We obtain P -1 -[1 -p + p(l -q)Tn]j. This equation describes a one-humped curve for the probability P as a function ofn. We are interested in the value of n that maximizes P. Table 1 shows this optimal value of n for a number of different parameter values q and f. In this analysis, n represents the total number of class I and class II molecules because these molecules select TCRs from a common pool.
To Proc. Natl. Acad. Sci. USA 89 (1992) 10899 then it is rare that a given TCR is positively selected by more than one MHC molecule. We obtain from Eq. 1:
Tn -Tohn(l -J7).
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From "P = 0 (using Eqs. 5 and 6) we obtain that the optimal number of different MHC molecules per individual is indirectly proportional to f, the fraction of TCRs deleted by a single MHC molecule in the thymus: k n =~~~~~~~ [ 7] f where k = 1 + [(1 -q)-Tn -1]/qTn. The factor k still depends on n, so Eq. 7 is transcendental in n. Using the approximation log(1 -q) -q, we can write k = (eqTn -1)/qTn + 1. The factor k is close to 2 for small values of the product qTn; for example, we have k = 2.05 for qT = 0.1 and k = 2.71 for qT = 1. The product qTn is the average number ofdifferent TCRs that bind to (and hence permit an effective immune response against) a given peptide-MHC complex. If this product is small, we find n = 2/f. [8] This result is rather surprising and simple; the optimal number of MHC molecules is simply twice the reciprocal of the fraction of TCRs deleted by a single MHC molecule. This approximation should be compared with the computed values in Table 1 . Thus, the crucial parameter of interest is the fraction f. Alloreactivity experiments lead to the crude estimate that 1-7% of the T-cell repertoire is reactive to multiple MHC disparities (refs. [15] [16] [17] and the references therein). This result may suggest a rather low value off and, therefore, a large value for the optimal n. It is not quite clear whether estimates based on alloreactivity can reflect the intrathymic situation. Another possibility may be to estimate the fraction f from in vitro experiments (18, 19) .
An important question is whether natural selection has resulted in an immune system with a number of MHC molecules close to the optimum, as calculated in our model. Is there a strong selective force to mount immune responses against all possible foreign peptides, or is it sufficient instead to recognize one or a few epitopes on a given pathogen? It may be very costly to have a very large number of different MHC molecules on every single cell in an animal. Our estimate gives the optimal number of different MHC molecules that maximizes the probability of recognizing a foreign peptide. This result may represent an upper limit of what we would expect to find in nature.
